ADAM8-Dependent Extracellular Signaling in the Tumor Microenvironment Involves Regulated Release of Lipocalin 2 and
Lena Cook1, Marie Sengelmann1, Birte Winkler1
1Department of Neurosurgery, Philipps University Marburg, Baldingerstr, 35033 Marburg, Germany.
Abstract:
The metalloprotease-disintegrin ADAM8 is critically involved in the progression of pancreatic cancer. Under malignant conditions, ADAM8 is highly expressed and could play an important role in cell-cell communication as expression has been observed in tumor and immune cells of the tumor microenvironment (TME) such as macrophages. To analyze the potential role of ADAM8 in the TME, ADAM8 knockout PDAC tumor cells were generated, and their release of extracellular vesicles (EVs) was analyzed. In EVs, ADAM8 is present as an active protease and associated with lipocalin 2 (LCN2) and matrix metalloprotease 9 (MMP-9) in an ADAM8-dependent manner, as ADAM8 KO cells show a lower abundance of LCN2 and MMP-9. Sorting of ADAM8 occurs independent of TSG101, even though ADAM8 contains the recognition motif PTAP for the ESCRTI protein TSG101 within the cytoplasmic domain (CD). When tumor cells were co-cultured with macrophages (THP-1 cells), expression of LCN2 and MMP-9 in ADAM8 KO cells was induced, suggesting that macrophage signaling can overcome ADAM8-dependent intracellular signaling in PDAC cells. In co-culture with macrophages, regulation of MMP-9 is independent of the M1/M2 polarization state, whereas LCN2 expression is preferentially affected by M1-like macrophages. From these data, we conclude that ADAM8 has a systemic effect in the tumor microenvironment, and its expression in distinct cell types has to be considered for ADAM8 targeting in tumors.
Insights
ADAM8 protease is crucial in pancreatic cancer progression and the tumor microenvironment. Its presence in extracellular vesicles influences cell communication, with macrophage signaling impacting ADAM8-dependent pathways.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- ADAM8 (a metalloprotease-disintegrin) is highly expressed in pancreatic cancer, suggesting a role in tumor progression and cell-cell communication within the tumor microenvironment (TME).
- ADAM8 expression is found in both tumor cells and immune cells like macrophages within the TME.
Purpose of the Study:
- To investigate the role of ADAM8 in the TME by analyzing extracellular vesicle (EV) release from ADAM8 knockout (KO) pancreatic ductal adenocarcinoma (PDAC) cells.
- To understand how macrophage signaling influences ADAM8 expression and associated molecules in PDAC cells.
Main Methods:
- Generation of ADAM8 knockout PDAC tumor cells.
- Analysis of extracellular vesicles (EVs) released by wild-type and ADAM8 KO cells.
- Co-culture experiments with PDAC cells and THP-1 macrophages.
- Assessment of LCN2 and MMP-9 expression and association with ADAM8 in EVs.
Main Results:
- ADAM8 is present as an active protease in EVs and associates with lipocalin 2 (LCN2) and matrix metalloprotease 9 (MMP-9) in an ADAM8-dependent manner.
- ADAM8 sorting into EVs is independent of TSG101.
- Co-culture with macrophages induced LCN2 and MMP-9 expression in ADAM8 KO cells, indicating macrophage signaling can modulate PDAC cell pathways.
- MMP-9 regulation by macrophages was independent of M1/M2 polarization, while LCN2 expression was preferentially affected by M1-like macrophages.
Conclusions:
- ADAM8 exerts a systemic effect within the tumor microenvironment.
- The expression of ADAM8 in different cell types within the TME is critical and must be considered for effective ADAM8-targeted cancer therapies.
Related Concept Videos
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
Role of Matrix Metalloproteases in Degradation of ECM
PI3K/mTOR/AKT Signaling Pathway
Cancer Cell Migration through Invadopodia


